These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31887743)

  • 1. Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized Controlled Trial.
    Conaghan PG; Bowes MA; Kingsbury SR; Brett A; Guillard G; Rizoska B; Sjögren N; Graham P; Jansson Å; Wadell C; Bethell R; Öhd J
    Ann Intern Med; 2020 Jan; 172(2):86-95. PubMed ID: 31887743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic and structural benefit of cathepsin K inhibition by MIV-711 in a subgroup with unilateral pain: post-hoc analysis of a randomised phase 2a clinical trial.
    Bihlet AR; Byrjalsen I; Andersen JR; Öberg F; Herder C; Bowes MA; Conaghan PG
    Clin Exp Rheumatol; 2022 May; 40(5):1034-1037. PubMed ID: 35238765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective cathepsin K inhibitor MIV-711 attenuates joint pathology in experimental animal models of osteoarthritis.
    Lindström E; Rizoska B; Tunblad K; Edenius C; Bendele AM; Maul D; Larson M; Shah N; Yoder Otto V; Jerome C; Grabowska U
    J Transl Med; 2018 Mar; 16(1):56. PubMed ID: 29523155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711.
    Lindström E; Rizoska B; Henderson I; Terelius Y; Jerling M; Edenius C; Grabowska U
    J Transl Med; 2018 May; 16(1):125. PubMed ID: 29743078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.
    Hochberg MC; Guermazi A; Guehring H; Aydemir A; Wax S; Fleuranceau-Morel P; Reinstrup Bihlet A; Byrjalsen I; Ragnar Andersen J; Eckstein F
    JAMA; 2019 Oct; 322(14):1360-1370. PubMed ID: 31593273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of
    Wang Z; Jones G; Winzenberg T; Cai G; Laslett LL; Aitken D; Hopper I; Singh A; Jones R; Fripp J; Ding C; Antony B
    Ann Intern Med; 2020 Dec; 173(11):861-869. PubMed ID: 32926799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical interventions for symptomatic mild to moderate knee osteoarthritis.
    Palmer JS; Monk AP; Hopewell S; Bayliss LE; Jackson W; Beard DJ; Price AJ
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012128. PubMed ID: 31322289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study.
    Henrotin Y; Bannuru R; Malaise M; Ea HK; Confavreux C; Bentin J; Urbin-Choffray D; Conrozier T; Brasseur JP; Thomas P; Hick AC; Marinello A; Giordan N; Richette P
    BMC Musculoskelet Disord; 2019 Jun; 20(1):293. PubMed ID: 31215422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study.
    Kuah D; Sivell S; Longworth T; James K; Guermazi A; Cicuttini F; Wang Y; Craig S; Comin G; Robinson D; Wilson J
    J Transl Med; 2018 Mar; 16(1):49. PubMed ID: 29510712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of low-intensity long-duration ultrasound on the symptomatic relief of knee osteoarthritis: a randomized, placebo-controlled double-blind study.
    Draper DO; Klyve D; Ortiz R; Best TM
    J Orthop Surg Res; 2018 Oct; 13(1):257. PubMed ID: 30326947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Intravenous Zoledronic Acid on Tibiofemoral Cartilage Volume Among Patients With Knee Osteoarthritis With Bone Marrow Lesions: A Randomized Clinical Trial.
    Cai G; Aitken D; Laslett LL; Pelletier JP; Martel-Pelletier J; Hill C; March L; Wluka AE; Wang Y; Antony B; Blizzard L; Winzenberg T; Cicuttini F; Jones G
    JAMA; 2020 Apr; 323(15):1456-1466. PubMed ID: 32315057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multicenter, Double-Blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of a Cell and Gene Therapy in Knee Osteoarthritis Patients.
    Kim MK; Ha CW; In Y; Cho SD; Choi ES; Ha JK; Lee JH; Yoo JD; Bin SI; Choi CH; Kyung HS; Lee MC
    Hum Gene Ther Clin Dev; 2018 Mar; 29(1):48-59. PubMed ID: 29641281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritis.
    Geusens P; Pavelka K; Rovensky J; Vanhoof J; Demeester N; Calomme M; Vanden Berghe D
    BMC Musculoskelet Disord; 2017 Jan; 18(1):2. PubMed ID: 28056936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Atorvastatin on Knee Cartilage Volume in Patients With Symptomatic Knee Osteoarthritis: Results From a Randomized Placebo-Controlled Trial.
    Wang Y; Jones G; Hill C; Wluka AE; Forbes AB; Tonkin A; Hussain SM; Ding C; Cicuttini FM
    Arthritis Rheumatol; 2021 Nov; 73(11):2035-2043. PubMed ID: 33844449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a Single Intra-Articular Injection of a Microsphere Formulation of Triamcinolone Acetonide on Knee Osteoarthritis Pain: A Double-Blinded, Randomized, Placebo-Controlled, Multinational Study.
    Conaghan PG; Hunter DJ; Cohen SB; Kraus VB; Berenbaum F; Lieberman JR; Jones DG; Spitzer AI; Jevsevar DS; Katz NP; Burgess DJ; Lufkin J; Johnson JR; Bodick N;
    J Bone Joint Surg Am; 2018 Apr; 100(8):666-677. PubMed ID: 29664853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.
    Fleischmann R; Sheldon E; Maldonado-Cocco J; Dutta D; Yu S; Sloan VS
    Clin Rheumatol; 2006 Feb; 25(1):42-53. PubMed ID: 16132165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
    Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
    Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
    Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
    Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pulsed Low-Intensity Ultrasonography on Symptom Relief and Tibiofemoral Articular Cartilage Thickness Among Veterans Affairs Enrollees With Knee Osteoarthritis: A Randomized Clinical Trial.
    Sawitzke AD; Jackson CG; Carlson K; Bizien MD; Leiner M; Reda DJ; Sindowski T; Hanrahan C; Spencer RG; Kwoh CK; Lee SJ; Hose K; Robin L; Cain DW; Taylor MD; Bangerter N; Finco M; Clegg DO
    JAMA Netw Open; 2022 Mar; 5(3):e220632. PubMed ID: 35258579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.
    Lohmander LS; Hellot S; Dreher D; Krantz EF; Kruger DS; Guermazi A; Eckstein F
    Arthritis Rheumatol; 2014 Jul; 66(7):1820-31. PubMed ID: 24740822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.